Brief Your CEO: New SCOTUS Case May Help Your Lab Defend Meritless Whistleblower Cases
A recent SCOTUS ruling on a healthcare fraud case could help defend labs against baseless whistleblower cases.
Brief Your CEO-lca
Subscribe today for access to
Articles and Reports
How to Explain the Current State of EKRA to Your Lab Executives
How to explain the current state of EKRA to your lab executives.
Brief Your CEO: The New Joint Commission Health Equity Standard
As of January 1, 2023, your lab may need to develop and implement a full-blown health equity plan to maintain its Joint Commission accreditation.
Make Sure Lab Staff Know about New CMS Clarification of IDTF Billing Rules
...
Already a member? Log in here
Brief Your CEO: New OCR Data Shed Light on the Costs of Privacy Noncompliance
...
Already a member? Log in here
The 18 Things You Can Do for COVID-19 that You Can’t Do for Other Testing
...
Already a member? Log in here
Brief Your CEO: Explain How New DOJ Guidance Can Get Your Lab Out of FCA Hot Water
From - Lab Compliance Advisor
New guidance from the DOJ lays out sheds light on a crucial matter that many high-ranking lab executives are forced to&…
Brief Your CEO: Notify Your Lab Execs of Upcoming Stark Law Changes
From - Lab Compliance Advisor
One of the best ways to score points with your lab's executives is to warn them about legal changes before they happen and…
Brief Your CEO: Real Stark Law Relief Might Actually Happen
From - G2 Compliance Advisor
Fool me once, shame on you; fool me twice, shame on me.
That may have been your reaction when you first heard about the new CMS Request for Information (RFI) seeking input on ways to…
Brief Your CEO: Medicaid Enforcement Trends & Their Impact on Labs
From - G2 Compliance Advisor
While they do not have to embroil themselves in the day-to-day compliance program details, the C-Suiters do need to be on top of…
Brief Your CEO: New Penalties Double the Dollar Value of Protecting Your Lab from Liability
From - G2 Compliance Advisor
You may not realize this, but Congress has just doubled the dollar value of what you do as a compliance manager to keep your…
Brief Your CEO: After 36 Years, CLIA Comes Under CMS Review
From - G2 Compliance Advisor
Even as your lab makes the transition to the new, supposedly market-based PAMA Medicare Part B fee schedule for tests, big changes may be in store for another rock of…